Volume 15, Issue 6, June 2008, in PDF

Article: 554
Covance, Kendle and i3 Research Are Top CROs in Europe
Results of the CenterWatch 2008 Survey of Investigative Sites in Europe found Covance the top rated contract research organization to work with.Also rated highly were Kendle and i3 Research.

Article: 555
The Time Is Now for CRO IPOs
A number of contract research organizations are considering filing for initial public offerings this year. Among those companies mentioned most are INC Research, United BioSource, CeteroResearch,Medpace—and even a return to the publicmarkets for Quintiles (or at leastpart of it).

Article: 556
EU Pediatric Regulations Get 18-Month Checkup
Workload, Unclear Incentives Raise Concerns
Eighteen months after the European Commission’s pediatric regulatory framework entered into force, stakeholders deliver mixed reports about its effect so far on pediatric drug development, though it is still early days to see concrete evidence of its impact. Initial optimism surrounding the potential of the regulation, as well as concerns about its possible drawbacks, persist in equal measure.

Article: 557
Eye On: Ocular Disorders
Two of themain causes of adult blindness in the developed world are agerelatedmacular degeneration (AMD) and diabetic retinopathy (DR). Severe visual loss in both diseases results from fluid accumulation around the retina as well as overgrowth of blood vessels in the back of the eye.